GSTM5 belongs to the Mu class of glutathione S‑transferases (GSTs), enzymes that catalyze conjugation of glutathione to electrophilic compounds. This biochemical category—phase II detoxification—helps make reactive molecules more water‑soluble and easier to clear. GSTM5 is expressed in several tissues and is part of a gene family studied for its role in cellular defense against environmental chemicals and metabolic byproducts. The rs3754446 site is a common single nucleotide polymorphism (SNP) within GSTM5 that has been evaluated in population and molecular studies. Research has examined how variants at this locus may affect gene expression or enzyme function; clinical relevance is best interpreted as part of broader biochemical and environmental context rather than on genotype alone.

When a person carries a GSTM5 genotype associated with higher predicted expression or activity, this pattern may align with relatively greater capacity to conjugate glutathione to reactive substrates—potentially matching lower levels of some oxidative stress markers in the same panel. Conversely, a genotype linked to reduced expression or activity can associate with weaker conjugation capacity and may coincide with higher oxidative damage signals or altered detox intermediates on urine testing. Interpretation should emphasize the combined picture: genetics provide predisposition, while the Cellular Zoomer’s oxidative, metabolic, and detox markers show current biochemical load and function.

GSTM5 (rs3754446) is included to connect inherited antioxidant capacity with real‑time measures of oxidative load and detox turnover. Evaluating this variant alongside lipid, DNA oxidation markers, glutathione turnover, and organic acids helps clinicians distinguish whether biochemical strain reflects current exposures, metabolic dysfunction, or an inherited tendency that shapes resilience.